Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kangji Medical Holdings Limited ( (HK:9997) ) just unveiled an update.
Kangji Medical Holdings Limited has announced the appointment of Somerley Capital Limited as the Independent Financial Adviser to guide the Independent Board Committee regarding the fairness and reasonableness of a proposed privatization scheme. This move is part of a broader strategy involving a scheme of arrangement under the Companies Act, with the aim of privatizing the company. The proposal’s implementation is contingent upon certain conditions being met, and stakeholders are advised to exercise caution.
The most recent analyst rating on (HK:9997) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Kangji Medical Holdings Limited stock, see the HK:9997 Stock Forecast page.
More about Kangji Medical Holdings Limited
Kangji Medical Holdings Limited is a company incorporated in the Cayman Islands, operating in the medical industry. It focuses on providing medical devices and solutions, with a market focus on surgical instruments and related technologies.
Average Trading Volume: 6,894,230
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.28B
For a thorough assessment of 9997 stock, go to TipRanks’ Stock Analysis page.